TIANF yields 2.37% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, TIANF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TIANF + PFE for your $10,000?
Tianneng Power International Limited, an investment holding company, engages in the production of motive batteries in the People's Republic of China and internationally. It operates in two segments, Sales of Batteries and Battery Related Accessories; and Trading of New Energy Materials. The company offers high-end eco-friendly batteries, such as two and three wheeled electric vehicle, start-stop, energy storage and backup, mini electric vehicle, and special electric vehicle batteries; new energy batteries, including lithium-ion and fuel cell batteries; and renewable new materials. It is also involved in recycling and cyclic utilization of waste batteries; and construction of smart micro-grids in cities, as well as building of green and smart industrial parks. In addition, it manufactures and sells electrode plates; sells metal materials; and offers finance lease. The company was founded in 1986 and is based in Wan Chai, Hong Kong.
Full TIANF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.